Cempra Pharmaceuticals.

Position:TRIANGLE
 
FREE EXCERPT

MORRISVILLE -- Cempra Pharmaceuticals, a startup that focuses on anti-infection drugs, added an investor to its first round of venture capital, pushing its take from $14 million to $22 million. New York-based Aisling Capital joined a group led by...

To continue reading

FREE SIGN UP